View in EDS

Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Saved in:
Bibliographic Details
Title: Incorporating Immunotherapies into the Evolving Standard of Care for Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.
Authors: Lissat A; Charité Universitätsmedizin, Berlin, Germany.; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Brivio E; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Stutterheim J; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Calkoen F; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands., Zwaan CM; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands., Bautista F; Department of Pediatric Hematology-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS, Utrecht, The Netherlands. f.j.bautistasirvent@prinsesmaximacentrum.nl.
Source: Paediatric drugs [Paediatr Drugs] 2026 Jul 23. Date of Electronic Publication: 2026 Jul 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2019 (Electronic) Linking ISSN: 11745878 NLM ISO Abbreviation: Paediatr Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2019
DOI:10.1007/s40272-026-00761-6